186 related articles for article (PubMed ID: 28557433)
1. Ligand-Mediated and Enzyme-Directed Precise Targeting and Retention for the Enhanced Treatment of Glioblastoma.
Ruan S; Xiao W; Hu C; Zhang H; Rao J; Wang S; Wang X; He Q; Gao H
ACS Appl Mater Interfaces; 2017 Jun; 9(24):20348-20360. PubMed ID: 28557433
[TBL] [Abstract][Full Text] [Related]
2. Increased Gold Nanoparticle Retention in Brain Tumors by in Situ Enzyme-Induced Aggregation.
Ruan S; Hu C; Tang X; Cun X; Xiao W; Shi K; He Q; Gao H
ACS Nano; 2016 Nov; 10(11):10086-10098. PubMed ID: 27934068
[TBL] [Abstract][Full Text] [Related]
3. A novel therapeutic strategy of multimodal nanoconjugates for state-of-the-art brain tumor phototherapy.
Kim HS; Seo M; Park TE; Lee DY
J Nanobiotechnology; 2022 Jan; 20(1):14. PubMed ID: 34983539
[TBL] [Abstract][Full Text] [Related]
4. iRGD-Mediated and Enzyme-Induced Precise Targeting and Retention of Gold Nanoparticles for the Enhanced Imaging and Treatment of Breast Cancer.
Yang Y; Chen Q; Li S; Ma W; Yao G; Ren F; Cai Z; Zhao P; Liao G; Xiong J; Yu Z
J Biomed Nanotechnol; 2018 Aug; 14(8):1396-1408. PubMed ID: 29903055
[TBL] [Abstract][Full Text] [Related]
5. VEGF-mediated tight junctions pathological fenestration enhances doxorubicin-loaded glycolipid-like nanoparticles traversing BBB for glioblastoma-targeting therapy.
Wen L; Tan Y; Dai S; Zhu Y; Meng T; Yang X; Liu Y; Liu X; Yuan H; Hu F
Drug Deliv; 2017 Nov; 24(1):1843-1855. PubMed ID: 29182025
[TBL] [Abstract][Full Text] [Related]
6. The Application of Ultrasmall Gold Nanoparticles (2 nm) Functionalized with Doxorubicin in Three-Dimensional Normal and Glioblastoma Organoid Models of the Blood-Brain Barrier.
Kostka K; Sokolova V; El-Taibany A; Kruse B; Porada D; Wolff N; Prymak O; Seeds MC; Epple M; Atala AJ
Molecules; 2024 May; 29(11):. PubMed ID: 38893345
[TBL] [Abstract][Full Text] [Related]
7. RGD and interleukin-13 peptide functionalized nanoparticles for enhanced glioblastoma cells and neovasculature dual targeting delivery and elevated tumor penetration.
Gao H; Xiong Y; Zhang S; Yang Z; Cao S; Jiang X
Mol Pharm; 2014 Mar; 11(3):1042-52. PubMed ID: 24521297
[TBL] [Abstract][Full Text] [Related]
8. Gold nanoparticles carrying or not anti-VEGF antibody do not change glioblastoma multiforme tumor progression in mice.
Silva VCJD; Silva RNO; Colli LG; Carvalho MHC; Rodrigues SF
Heliyon; 2020 Nov; 6(11):e05591. PubMed ID: 33294714
[TBL] [Abstract][Full Text] [Related]
9. Doxorubicin-loaded oligonucleotide conjugated gold nanoparticles: A promising in vivo drug delivery system for colorectal cancer therapy.
Lee CS; Kim H; Yu J; Yu SH; Ban S; Oh S; Jeong D; Im J; Baek MJ; Kim TH
Eur J Med Chem; 2017 Dec; 142():416-423. PubMed ID: 28870452
[TBL] [Abstract][Full Text] [Related]
10. Investigation on the effect of nanoparticle size on the blood-brain tumour barrier permeability by in situ perfusion via internal carotid artery in mice.
Kang JH; Cho J; Ko YT
J Drug Target; 2019 Jan; 27(1):103-110. PubMed ID: 29972326
[TBL] [Abstract][Full Text] [Related]
11. A gain of function paradox: Targeted therapy for glioblastoma associated with abnormal NHE9 expression.
Pall AE; Juratli L; Guntur D; Bandyopadhyay K; Kondapalli KC
J Cell Mol Med; 2019 Nov; 23(11):7859-7872. PubMed ID: 31532058
[TBL] [Abstract][Full Text] [Related]
12. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
[TBL] [Abstract][Full Text] [Related]
13. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment.
Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X
J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064
[TBL] [Abstract][Full Text] [Related]
15. Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma.
Janjua TI; Ahmed-Cox A; Meka AK; Mansfeld FM; Forgham H; Ignacio RMC; Cao Y; McCarroll JA; Mazzieri R; Kavallaris M; Popat A
Nanoscale; 2021 Oct; 13(40):16909-16922. PubMed ID: 34533167
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Orthotopic U251 Human Glioblastoma Multiforme Tumors in NRG Mice by Convection-Enhanced Delivery of Gold Nanoparticles Labeled with the β-Particle-Emitting Radionuclide,
Georgiou CJ; Cai Z; Alsaden N; Cho H; Behboudi M; Winnik MA; Rutka JT; Reilly RM
Mol Pharm; 2023 Jan; 20(1):582-592. PubMed ID: 36516432
[TBL] [Abstract][Full Text] [Related]
17. Dual-Energy CT Imaging of Tumor Liposome Delivery After Gold Nanoparticle-Augmented Radiation Therapy.
Ashton JR; Castle KD; Qi Y; Kirsch DG; West JL; Badea CT
Theranostics; 2018; 8(7):1782-1797. PubMed ID: 29556356
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of 2.4 nm thiolate-protected gold nanoparticles conjugated to Cetuximab for targeting glioblastoma cancer cells via the EGFR.
Groysbeck N; Stoessel A; Donzeau M; da Silva EC; Lehmann M; Strub JM; Cianferani S; Dembélé K; Zuber G
Nanotechnology; 2019 May; 30(18):184005. PubMed ID: 30650397
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles.
Ruan S; Yuan M; Zhang L; Hu G; Chen J; Cun X; Zhang Q; Yang Y; He Q; Gao H
Biomaterials; 2015 Jan; 37():425-35. PubMed ID: 25453970
[TBL] [Abstract][Full Text] [Related]
20. Near Infrared Fluorescent Nanoplatform for Targeted Intraoperative Resection and Chemotherapeutic Treatment of Glioblastoma.
Reichel D; Sagong B; Teh J; Zhang Y; Wagner S; Wang H; Chung LWK; Butte P; Black KL; Yu JS; Perez JM
ACS Nano; 2020 Jul; 14(7):8392-8408. PubMed ID: 32551496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]